SynthesisFrontiers in pharmacology2022

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis.

Mingye Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.